NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Start Multiple Choice Practice Test
Start Flash Cards

Practice this question and more.

Esketamine (Spravato) is indicated for:

  1. Common cold symptoms

  2. Epilepsy

  3. Treatment-resistant depression and depression with suicidality

  4. Migraine headaches

The correct answer is: Treatment-resistant depression and depression with suicidality

Esketamine (Spravato) is indicated for the treatment of treatment-resistant depression and depression with suicidality. It is a nasal spray medication that acts as a glutamate receptor modulator. This medication is specifically approved for patients who have not found relief with other antidepressant treatments. Options A, B, and D are incorrect because Esketamine is not indicated for the treatment of common cold symptoms, epilepsy, or migraine headaches.

More Questions Like This